Azalomycin-B 5mg 5mg | Purity Not Available
Adooq Bioscience
Azalomycin-B is a macrolide antibiotic produced by Streptomyces hygroscopicus.
More Information Supplier PageAzalomycin-B is a macrolide antibiotic produced by Streptomyces hygroscopicus.
More Information Supplier PageAzalomycin-B is a macrolide antibiotic produced by Streptomyces hygroscopicus.
More Information Supplier PageAzalomycin-B is a macrolide antibiotic produced by Streptomyces hygroscopicus.
More Information Supplier PageAzalomycin-B is a macrolide antibiotic produced by Streptomyces hygroscopicus.
More Information Supplier PageTivozanib (AV-951) is an oral VEGF receptor tyrosine kinase inhibitor that is designed to inhibit all three VEGF receptors.
More Information Supplier PageTivozanib (AV-951) is an oral VEGF receptor tyrosine kinase inhibitor that is designed to inhibit all three VEGF receptors.
More Information Supplier PageTivozanib (AV-951) is an oral VEGF receptor tyrosine kinase inhibitor that is designed to inhibit all three VEGF receptors.
More Information Supplier PageAurora A Inhibitor I is a potent and selective inhibitor of Aurora A kinase (AurA), with IC50 values to be 3.4 nM (Aurora A) and unusually high selectivity 1000 fold against Aurora B; a useful tool compound for investigating the cellular role of Aurora A kinases.
More Information Supplier PageAurora A Inhibitor I is a potent and selective inhibitor of Aurora A kinase (AurA), with IC50 values to be 3.4 nM (Aurora A) and unusually high selectivity 1000 fold against Aurora B; a useful tool compound for investigating the cellular role of Aurora A kinases.
More Information Supplier PageAurora A Inhibitor I is a potent and selective inhibitor of Aurora A kinase (AurA), with IC50 values to be 3.4 nM (Aurora A) and unusually high selectivity 1000 fold against Aurora B; a useful tool compound for investigating the cellular role of Aurora A kinases.
More Information Supplier Page